Published November 6, 2017 | Version v1
Journal article Open

Mutations that impair Eyes absent tyrosine phosphatase activity in vitro reduce robustness of retinal determination gene network output in Drosophila

  • 1. University of Chicago

Description

A limited collection of signaling networks and transcriptional effectors directs the full spectrum of cellular behaviors that comprise development. One mechanism to diversify regulatory potential is to combine multiple biochemical activities into the same protein. Exemplifying this principle of modularity, Eyes absent (Eya), originally identified as a transcriptional co-activator within the retinal determination gene network (RDGN), also harbors tyrosine and threonine phosphatase activities. Although mounting evidence argues for the importance of Eya's phosphatase activities to mammalian biology, genetic rescue experiments in Drosophila have shown that the tyrosine phosphatase function is dispensable for normal development. In this study, we repeated these rescue experiments in genetically sensitized backgrounds in which the dose of one or more RDGN factor was reduced. Heterozygosity for sine oculis or dachshund, both core RDGN members, compromised the ability of phosphatase-dead eya, but not of the control wild type eya transgene, to rescue the retinal defects and reduced viability associated with eya loss. We speculate that Eya's tyrosine phosphatase activity, although non-essential, confers robustness to RDGN output.

Data availability

All relevant data are within the paper.

Files

journal.pone.0187546.pdf

Files (10.8 MB)

Name Size Download all
Article
md5:650f3333ea978d9944ce4eacf183090b
10.8 MB Preview Download

Additional details

Identifiers

DOI
10.1371/journal.pone.0187546
Other
oai:uchicago.tind.io:6585

Funding

National Institute of Health
R01 EY12549
National Institute of Health
P30 CA014599
National Institute of Health
T32 GM07197
National Institute of Health
T32 HD055164

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Ben May Department for Cancer Research, Development, Regeneration, and Stem Cell Biology, Genetics, Genomics, and Systems Biology